tiprankstipranks
Gilead Sciences (GILD)
NASDAQ:GILD
Holding GILD?
Track your performance easily

Gilead Sciences (GILD) Financial Statements

12,920 Followers

Gilead Sciences Financial Overview

Gilead Sciences's market cap is currently ―. The company's EPS TTM is $0.088; its P/E ratio is 989.29; and it has a dividend yield of 3.49%. Gilead Sciences is scheduled to report earnings on February 11, 2025, and the estimated EPS forecast is $1.72. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 7.54B$ 6.95B$ 6.69B$ 7.12B$ 7.05B
Gross Profit$ 5.97B$ 5.41B$ 5.13B$ 5.03B$ 5.49B
EBIT$ 956.00M$ 2.05B$ -4.23B$ 1.91B$ 2.55B
EBITDA$ 1.65B$ 2.75B$ -3.54B$ 2.59B$ 3.23B
Net Income Common Stockholders$ 1.25B$ 1.61B$ -4.17B$ 1.43B$ 2.18B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 0.00$ 0.00$ 1.18B$ 1.16B
Total Assets$ 54.52B$ 53.58B$ 56.29B$ 62.13B$ 62.37B
Total Debt$ 23.25B$ 23.35B$ 25.19B$ 24.99B$ 24.98B
Net Debt$ 23.25B$ 23.35B$ 25.19B$ 23.81B$ 23.82B
Total Liabilities$ 36.13B$ 35.38B$ 38.84B$ 39.38B$ 40.13B
Stockholders Equity$ 18.48B$ 18.28B$ 17.54B$ 22.83B$ 22.31B
Cash Flow-
Free Cash Flow$ 4.17B$ 1.20B$ 2.11B$ 1.95B$ 1.63B
Operating Cash Flow$ 4.31B$ 1.32B$ 2.22B$ 2.17B$ 1.75B
Investing Cash Flow$ -710.00M$ -307.00M$ -2.21B$ -727.00M$ -229.00M
Financing Cash Flow$ -1.38B$ -2.95B$ -1.36B$ -1.10B$ -1.52B
Currency in USD

Gilead Sciences Earnings and Revenue History

Gilead Sciences Debt to Assets

Gilead Sciences Cash Flow

Gilead Sciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis